Skip to main content
Chad Heatwole, MD, Neurology, Rochester, NY, Highland Hospital

ChadRHeatwoleMD

Neurology Rochester, NY

Neuromuscular Medicine, Neurophysiology

Assistant Professor, Neurology, University of Rochester School of Medicine & Dentistry

Are you Dr. Heatwole?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 65 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Chad Heatwole, MD is a board certified neurologist in Rochester, New York. He is currently licensed to practice medicine in New York and Florida. He is affiliated with Strong Memorial Hospital of the University of Rochester, Highland Hospital, and Rochester General Hospital.

Education & Training

  • University of Rochester
    University of RochesterFellowship, Clinical Neurophysiology, 2005 - 2006
  • University of Rochester
    University of RochesterResidency, Neurology, 2002 - 2005
  • University of Rochester
    University of RochesterInternship, Internal Medicine, 2001 - 2002
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2001

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2003 - 2025
  • FL State Medical License
    FL State Medical License 2012 - 2014
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Neuromuscular Medicine

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Huntington Disease Health Index Accurate for Patient-Reported Changes in Symptom Burden
    Huntington Disease Health Index Accurate for Patient-Reported Changes in Symptom BurdenMay 14th, 2023
  • SMA in Adults: Interim Data Back Nusinersen Efficacy
    SMA in Adults: Interim Data Back Nusinersen EfficacyApril 27th, 2023
  • UR Clinical Researchers Get $2.9 Million Award
    UR Clinical Researchers Get $2.9 Million AwardNovember 15th, 2022
  • Join now to see all

Grant Support

  • The Development And Use Of A Disease-Specific Instrument For Myotonic DystophyNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2011

Hospital Affiliations